NCT04726280View on ClinicalTrials.gov

Respiratory Impact of LA Volume After IS Block

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

November 20, 2023

Study Completion Date

November 20, 2023

Conditions
Arthroscopic Surgery of the ShoulderExtrafascial Interscalene Plexus Brachial Block
Interventions
DRUG

Ropivacaine 0.75% Injectable Solution

10 ml extrafascial interscalene brachial plexus block

DRUG

Ropivacaine 0.75% Injectable Solution

20 ml extrafascial interscalene brachial plexus block

Trial Locations (1)

1011

CHUV (Centre Hospitalier Universitaire Vaudois), Lausanne

All Listed Sponsors
lead

Eric Albrecht

OTHER

NCT04726280 - Respiratory Impact of LA Volume After IS Block | Biotech Hunter | Biotech Hunter